- ►annals.org [PDF] L Aviles-Santa, J Sinding, P Raskin - Annals of Internal Medicine, 1999 - Am Coll Physicians Larissa Avilés-Santa, MD; Joyce Sinding, MSN, RN; and Philip Raskin, MD ...
Background: Patients with type 2 diabetes are often obese and require large
doses of insulin to achieve glyce- mic control. Weight gain often ... Cited by 167 - Related articles - BL Direct - All 5 versions
- ►annals.org [PDF] H Yki-Jarvinen, L Ryysy, K Nikkila, T Tulokas … - Annals of internal medicine, 1999 - Am Coll Physicians Hannele Yki-Järvinen, MD; Leena Ryysy, MD; Kati Nikkilä, MD; Timo Tulokas, MD;
Raimo Vanamo, MD; and Marjatta Heikkilä, RN ... Background: Compared with
other insulin regimens, combination therapy with oral hypoglycemic agents ... Cited by 366 - Related articles - BL Direct - All 6 versions
F Relimpio, A Pumar, F Losada, MA Mangas, … - Diabetic Medicine, 1998 - interscience.wiley.com To compare the effect of adding metformin to insulin therapy with a moderate
increase in insulin dose alone in insulin-treated, poorly controlled Type 2
diabetic patients, 47 consecutive such patients (baseline daily dose >0.5 ... Cited by 42 - Related articles - BL Direct - All 4 versions
JL Johnson, SL Wolf, UM Kabadi - Archives of Internal Medicine, 1996 - archinte.highwire.org Background: Numerous studies demonstrate the effi- cacy of the combination
therapy ofinsulin and sulfonyl- urea in subjects with type II diabetes mellitus.
However, two recent meta-analyses ofrandomized trials during the Cited by 142 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org [PDF] MC Riddle, J Schneider - Diabetes Care, 1998 - Am Diabetes Assoc F rom the Oregon Health Sciences University (MCR), Portland, Oregon; and Hoechst
Marion Roussel Phar- maceuticals (JS), Somerville, New Jersey. A dd ress
correspondence and reprint requests to Matthew C. Riddle, MD, Section of ... Cited by 82 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org [PDF] AC Robinson, J Burke, S Robinson, DG … - Diabetes Care, 1998 - Am Diabetes Assoc Study 1 The study was approved by the local re sea rch ethics committee of the
Kensing- ton, Chelsea, and Westminster Health A uthorit y. Patients with NIDDM
were selected from a teaching hospital outpatient diabetic clinic. The ... Cited by 98 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org SM Strowig, ML Avilés-Santa, P Raskin - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—HbA lc levels decreased in all groups, the lowest level occurring in
the insulin plus troglitazone group (insulin alone to 7.0%, insulin plus
metformin to 7.1%, and insulin plus troglitazone to 6.4%, P < 0.0001). The ... Cited by 61 - Related articles - BL Direct - All 6 versions
CC Chow, LW Tsang, JP Sorensen, CS … - Diabetes Care, 1995 - Am Diabetes Assoc OBJECTIVES--Optimal insulin regimens for non-insulin-dependent diabetes mellitus
(NIDDM) patients with secondary failure are controversial. We evaluated the
efficacy, side effects, and quality of life of patients receiving insulin ... Cited by 109 - Related articles - BL Direct - All 7 versions
HH Ponssen, JWF Elte, P Lehert, JP Schouten … - Clinical therapeutics, 2000 - Elsevier Thirty-one patients (24 women, 7 men; mean age, 61.8 years; mean body mass index
[BMI], 28.0 kg/m 2 ) were enrolled in this randomized, double-blind, 2-way,
crossover, placebo-controlled study. Patients with type 2 diabetes who were ... Cited by 27 - Related articles - BL Direct - All 5 versions
D Giugliano, A Quatraro, G Consoli, A Minei, A … - European journal of clinical pharmacology, 1993 - Springer Summary, The efficacy and safety of metformin in the treatment of obese,
non-insulin-dependent, diabetic sub- jects poorly controlled by insulin after
secondary failure to respond to sulphonylureas has been investigated. Fifty ... Cited by 122 - Related articles - BL Direct - All 3 versions
